About this journal

Delivering therapeutics in a way that is right for the patient - safe, painless, reliable, targeted, efficient and cost effective - is the fundamental aim of scientists working in this area. Correspondingly, this evolving field has already yielded a diversity of delivery methods, including injectors, controlled release formulations, drug eluting implants and transdermal patches. Rapid technological advances and the desire to improve the efficacy and safety profile of existing medications by specific targeting to the site of action, combined with the drive to improve patient compliance, continue to fuel rapid research progress. Furthermore, the emergence of cell-based therapeutics and biopharmaceuticals such as proteins, peptides and nucleotides presents scientists with new and exciting challenges for the application of therapeutic delivery science and technology.

Successful delivery strategies increasingly rely upon collaboration across a diversity of fields, including biology, chemistry, pharmacology, nanotechnology, physiology, materials science and engineering. Therapeutic Delivery recognizes the importance of this diverse research platform and encourages the publication of articles that reflect the highly interdisciplinary nature of the field.

In a highly competitive industry, Therapeutic Delivery provides the busy researcher with a forum for the rapid publication of original research and critical reviews of all the latest relevant and significant developments, and focuses on how the technological, pharmacological, clinical and physiological aspects come together to successfully deliver modern therapeutics to patients. The journal delivers this essential information in concise, at-a-glance article formats that are readily accessible to the full spectrum of therapeutic delivery researchers.

Articles published in Therapeutic Delivery cover key areas such as:

• Delivery of small molecule drugs, vaccines, radionuclides, proteins, peptides, genes, siRNA, nucleotides, stem cells and diagnostic probes
• Targeting at the molecular, cellular, organ and systemic levels
• Techniques for crossing biological barriers
• Methods for enhancement of pharmacokinetic profiles
• Absorption/distribution pharmacokinetics in relation to drug delivery
• Biodynamic and bioresponsive delivery
• Stimuli triggered delivery
• Parenteral delivery
• Nanotechnology
• Personalized therapeutic delivery
• Drug release mechanisms
• Combination products and delivery devices
• Design and characterization of dosage forms
• Drug formulation research and development
• Physiochemical and biological properties of drugs
• Intellectual property, competitor intelligence and partnering news
• Cost / benefit analyses
• In vitro, in vivo and in silico delivery studies
• Emerging technologies

The journal welcomes unsolicited article proposals.

Senior Editor

Banga AK, Mercer University, Atlanta, GA, USA

Associate Editors

Chow MSS, Western University of Health Sciences, CA, USA
Dinh S, CutisPharma, Wilmington, MA, USA
Prud'homme RK, Princeton University, NJ, USA
Tendler S, University of York, UK
Wang G, China Pharmaceutical University, China

International Editorial Advisory Board

Al-Salami H,Curtin University, Perth, Australia
Arora M, University of Alamaba, AL, USA
Bakshi P,GlaxoSmithKline, VA, USA
Bhattacharjee H, The University of Tennessee Health Science Center, TN, USA
Das S, Bulter University, College of Pharmacy & Health Sciences, IN, USA
Dash AK, Creighton University, NE, USA
Destache C, Creighton University, NE, USA
Gabathuler R, Cydweli Consultants Inc., Quebec, Canada
Greish K,Arabian Gulf University, Kingdom of Bahrain
Goswami T, Senior Manager, Amneal Pharmaceuticals, NJ, USA
Heng P, National University of Singapore, Singapore
Ho P, National University of Singapore, Singapore
Ho RJY, University of Washington, USA
Jia L, National Institutes of Health (NIH), Bethesda, USA
Jelvehgari M, University of Tabriz, Tabriz, Iran
Jones DS, The Queen's University of Belfast, Medical Biology Centre, School of Pharmacy, Northern Ireland, UK
Khan Ghilzai N, School of Pharmacy, West Coast University, CA, USA
Khang G, Chonbuk National University, Korea
Lee BJ, Ajou University, Republic of Korea
Li S,Queen's University Belfast, Northern Ireland, UK
Matsumura Y, National Cancer Center Hospital East, Japan
Mandal S, University of Nebraska-Lincoln, NE, USA
McCartney F, University College Dublin, Republic of Ireland
Medintz I, U.S. Naval Research Laboratory Code 6900, USA
Miller AD, Imperial College Genetic Therapies Centre, UK
Mohammed AR, Aston University, UK
Moridani M, Medical College of Wisconsin, USA
Müllertz A, University of Copenhagen, Denmark
Nadia Passerini,University of Bologna, Italy
Rautio J, University of Eastern Finland, Finland
Rees G, Genesis Oral, UK
Reis C, Universidade Lusófona de Humanidades e Tecnologias, Portugal
Rosenmayr-Templeton L, Tower Pharma Consulting, Austria
Shameem M, Regeneron Pharmaceuticals, Tarrytown, NY, USA
Stinchcomb AL, University of Kentucky and AllTranz Inc, Lexington, KY, USA
Sun D, The University of Michigan, MI, USA
Tambuwala M, Ulster University, Northern Ireland, UK
Tiwary AK, Department of Pharmaceutical Sciences & Drug Research, Punjabi University, Patiala, India
Uchegbu IF, University of London, UK
Vig B, Bristol-Myers Squibb, USA
Younes HM, Qatar University, Qatar
Zinzalla G, Karolinska Institute, Sweden